$Different effects of dopaminergic medications on subthalamic beta bursts and non-oscillatory fractal components in parkinson’s disease: a longitudinal study$
QR Code

QR Code

Different effects of dopaminergic medications on subthalamic beta bursts and non-oscillatory fractal components in parkinson’s disease: a longitudinal study

Saved in:

Bibliographic Details
Main Authors:	Ghazaleh Darmani, Neil Drummond, Hamidreza Ramezanpour, Ke Zeng, Kaviraja Udupa, Can Sarica, William D. Hutchison, Andres Lozano, Alfonso Fasano, Robert Chen
Format:	article
Language:	EN
Published:	Elsevier 2021
Subjects:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571
Online Access:	https://doaj.org/article/16a6a12fbb784f30bd04a5723e9a2b5b
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Dopaminergic Modulation of Spectral and Spatial Characteristics of Parkinsonian Subthalamic Nucleus Beta Bursts
by: Matthias Sure, et al.
Published: (2021)

Amplitude and frequency modulation of subthalamic beta oscillations as biomarkers of the dopaminergic state in Parkinson’s disease
by: Alberto Averna, et al.
Published: (2021)

Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson’s Disease
by: Zhao XM, et al.
Published: (2020)

Asymmetry of Subthalamic Neuronal Firing Rate and Oscillatory Characteristics in Parkinson’s Disease [Retraction]
by: Zhao XM, et al.
Published: (2020)

Impaired reach-to-grasp kinematics in parkinsonian patients relates to dopamine-dependent, subthalamic beta bursts
by: Matteo Vissani, et al.
Published: (2021)

Oscillatory bursting of gel fuel droplets in a reacting environment
by: Ankur Miglani, et al.
Published: (2017)

Induction of human motor cortex plasticity by theta burst transcranial ultrasound stimulation
by: Ke Zeng, et al.
Published: (2021)

Eight-hours conventional versus adaptive deep brain stimulation of the subthalamic nucleus in Parkinson’s disease
by: Tommaso Bocci, et al.
Published: (2021)

Subthalamic and pallidal deep brain stimulation for Parkinson’s disease—meta-analysis of outcomes
by: M. Lenard Lachenmayer, et al.
Published: (2021)

Subthalamic stimulation breaks the balance between distal and axial signs in Parkinson’s disease
by: Cyril Atkinson-Clement, et al.
Published: (2021)

Weight gain is associated with medial contact site of subthalamic stimulation in Parkinson's disease.
by: Filip Růžička, et al.
Published: (2012)

Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson’s disease
by: Kai Li, et al.
Published: (2017)

Impulsivities and Parkinson's disease: delay aversion is not worsened by Deep Brain Stimulation of the subthalamic nucleus.
by: Diana M E Torta, et al.
Published: (2012)

Cortical and Cerebellar Oscillatory Responses to Postural Instability in Parkinson's Disease
by: Taylor J. Bosch, et al.
Published: (2021)

Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?
by: MA Qamar, et al.
Published: (2017)

How accurately are subthalamic nucleus electrodes implanted relative to the ideal stimulation location for Parkinson's disease?
by: Patrick Pearce, et al.
Published: (2021)

Altered emotional prosody processing in patients with Parkinson’s disease after subthalamic nucleus stimulation
by: Jin Y, et al.
Published: (2017)

Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease
by: Stefanie T. Jost, et al.
Published: (2021)

Editorial: Novel Multimodal Approaches in Non-invasive Brain Stimulation
by: Nivethida Thirugnanasambandam, et al.
Published: (2021)

The rostro-caudal gradient in the prefrontal cortex and its modulation by subthalamic deep brain stimulation in Parkinson’s disease
by: F. Konrad Schumacher, et al.
Published: (2021)

TFE3-Mediated Autophagy is Involved in Dopaminergic Neurodegeneration in Parkinson’s Disease
by: Xin He, et al.
Published: (2021)

Differential Effects of Pathological Beta Burst Dynamics Between Parkinson’s Disease Phenotypes Across Different Movements
by: Raumin S. Neuville, et al.
Published: (2021)

Lack of progression of beta dynamics after long‐term subthalamic neurostimulation
by: Ross W. Anderson, et al.
Published: (2021)

Arm swing responsiveness to dopaminergic medication in Parkinson’s disease depends on task complexity
by: Elke Warmerdam, et al.
Published: (2021)

CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
by: Nora Bengoa-Vergniory, et al.
Published: (2020)

Genetic factors affecting dopaminergic deterioration during the premotor stage of Parkinson disease
by: Myung Jun Lee, et al.
Published: (2021)

Dopaminergic pathways and resting-state functional connectivity in Parkinson’s disease with freezing of gait
by: Kenan Steidel, et al.
Published: (2021)

Balance response to levodopa predicts balance improvement after bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease
by: Zixiao Yin, et al.
Published: (2021)

Effects of subthalamic nucleus deep brain stimulation on emotional working memory capacity and mood in patients with Parkinson's disease
by: Merkl A, et al.
Published: (2017)

Electroceutically induced subthalamic high-frequency oscillations and evoked compound activity may explain the mechanism of therapeutic stimulation in Parkinson’s disease
by: Musa Ozturk, et al.
Published: (2021)

Deep brain stimulation of pallidal versus subthalamic for patients with Parkinson's disease: a meta-analysis of controlled clinical trials
by: Xu F, et al.
Published: (2016)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
by: Ingrid Morales, et al.
Published: (2021)

Efficacies of globus pallidus stimulation and subthalamic nucleus stimulation for advanced Parkinson's disease: a meta-analysis of randomized controlled trials
by: Tan ZG, et al.
Published: (2016)

Posterior subthalamic nucleus (PSTh) mediates innate fear-associated hypothermia in mice
by: Can Liu, et al.
Published: (2021)

Conditional disruption of AMP kinase in dopaminergic neurons promotes Parkinson's disease-associated phenotypes in vivo
by: Liting Hang, et al.
Published: (2021)

Hybrid PET-MRI for early detection of dopaminergic dysfunction and microstructural degradation involved in Parkinson’s disease
by: Song’an Shang, et al.
Published: (2021)

Dysregulation of mitochondria-lysosome contacts by GBA1 dysfunction in dopaminergic neuronal models of Parkinson’s disease
by: Soojin Kim, et al.
Published: (2021)

Response inhibition in Parkinson’s disease: a meta-analysis of dopaminergic medication and disease duration effects
by: Peter Manza, et al.
Published: (2017)

Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson’s disease
by: Julia Benkert, et al.
Published: (2019)

Effects of dopaminergic drug adjustment on executive function in different clinical stages of Parkinson’s disease
by: Murakami H, et al.
Published: (2017)